Possible scenario
Jev Mounts Response
18% Chance
Jev responds quickly with a new clinical decision model, revised benchmark submission, or partnership to defend its position. Given Jev’s recent benchmark leadership, a partial rebound is plausible even if open-weight rivals keep momentum.
Secondary impacts
- Technology +0.3%
- Healthcare +0.1%
Tickers
- NVDA+0.5%
Portfolio impact
S&P 500+0.2%
Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.
Keeping an eye on this scenario?
Tilt can alert you when its probability or impact shifts, or send you a recommendation when it crosses a threshold.